Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 3, 1999, Pages 488-494

  Migot Nabias, F ^a   Luty, A J F ^b   Ringwald, P ^c   Vaillant, M ^d   Dubois, B ^e   Renaut, A ^f   Mayombo, J ^a   Minh, T N ^a   Fievet, N ^c   Mbessi, J R ^g   Millet, P ^d   Deloron, P ^a  

^a CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^b Institut fur Tropenmedizin   (Germany)

^c Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e BICHAT HOSPITAL   (France)

^f Bur Intl Gestion d'Etud P   (France)

^g Hôpital St André   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CAMEROON; CELLULAR IMMUNITY; CHILD; CYTOKINE RELEASE; DISEASE PREDISPOSITION; FEMALE; GABON; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032843794     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.488     Document Type: Article

References (32)

1. Ridley RG, Takacs B, Etlinger H, Scaife JG, 1990. A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys. Parasitology 101: 187-192.
2. Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, Hoffman SL, 1994. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 343: 564-568.
3. Pasloske BL, Howard RJ, 1994. The promise of asexual malaria vaccine development. Am J Trop Med Hyg 50 (suppl 4): 3-10.
4. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, Schonfeld H-A, Holder AA, Greenwood BM, 1992. Naturally acquired cellular and humoral responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 14: 321-337.
5. Tolle R, Früh K, Doumbo O, Koita O, N'Diaye M, Fisher A, Dietz K, Bujard H, 1993. A prospective study of the association between the humoral response to Plasmodium falciparum blood stage antigen gp 190 and control of malarial infections. Infect Immun 61: 40-47.
6. Al-Yaman F, Genton B, Kramer KJ, Chang SP, Hui GS, Baisor M, Alpers MP, 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg 54: 443-448.
7. Egan AF, Morris J, Burnish G, Allen S, Greenwood BM, Kaslow DC, Holder AA, Riley EM, 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 173: 765-769.
8. Al-Yaman F, Genton B, Anders R, Taraika J, Ginny M, Mellor S, Alpers MP, 1995. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 17: 493-501.
9. Al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP, 1997. Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area. Parasite Immunol 19: 249-254.
10. Jakobsen PH, Lemnge MM, Abu-Zeid YA, Msangeni HA, Salum FM, Mhina JIK, Akida JA, Ruta AS, Ronn AM, Heegaard PMH, Ridley RG, Bygbjerg IC, 1996. Immunoglobulin G reactivities to rhoptry-associated-protein-1 associated with decreased levels of Plasmodium falciparum parasitemia in Tanzanian children. Am J Trop Med Hyg 55: 642-646.
11. World Health Organization, 1994. World malaria situation in 1992. WkIy Epidemiol Rec 69: 309-314.
12. Deloron P, Ringwald P, Luty AJF, Renaut A, Minh TN, Mbessy JR, Millet P, 1999. Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa. Am J Trop Med Hyg 61: 99-102.
13. Luty AJF, Mayombo J, Lekoulou F, Mshana R, 1994. Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection. Am J Trop Med Hyg 51: 720-729.
14. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the Saker-Solomons test: simple, reliable colorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
15. Tanabe K, Mackay M, Goman M, Scaife J, 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum merozoites. J Mol Biol 195: 273-278.
16. Rzepczyk CM, Ramasamy R, Mutch DA, Ho PC-L, Battistutta D, Anderson KL, Parkinson D, Doran TJ, Honeyman M, 1989. Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens. Eur J Immunol 19: 1797-1802.
17. Ridley RG, Takacs B, Lahm H-W, Delves CJ, Goman M, Certa U, Matile H, Woollett GR, Scaife JG, 1990. Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum. Mol Biochem Parasitol 41: 125-134.
18. Wellems TE, Howard RJ, 1986. Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci USA 83: 6065-6069.
19. Favaloro JM, Coppel RL, Corcoran LM, Foote SJ, Brown GV, Anders RF, Kemp DJ, 1986. Structure of the RESA gene of Plasmodium falciparum. Nucleic Acids Res 14: 8265-8277.
20. Rzepczyk CM, Ramasamy R, Ho PC-L, Mutch DA, Andersen KL, Duggelby RG, Doran TJ, Murray BJ, Irving DO, Woodrow GC, Parkinson D, Brabin BJ, Alpers MP, 1988. Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and non-repeat regions of Pf155/RESA. J Immunol 141: 3197-3202.
21. Deloron P, Campbell GH, Brandling-Bennett D, Roberts JM, Schwartz IK, Odera JS, LaI AA, Osanga CO, Cruz V, McCutchan T, 1989. Antibodies to Plasmodium falciparum ring-infected erythrocyte surface antigen and P. falciparum and P. malariae circumsporozoite proteins: seasonal prevalence in Kenyan villages. Am J Trop Med Hyg 41: 395-399.
22. Rasheed FN, Bulmer JN, De Francisco A, Jawla MFB, Jakobsen PH, Jepson A, Greenwood BM, 1995. Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunol 17: 1-10.
23. Kabilan L, Sharma VP, Kaur P, Ghosh SK, Yadav RS, Chauhan VS, 1994. Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic. Infect Immun 62: 685-691.
24. Udomsangpetch R, Troye-Blomberg M, Brown AE, Thaithong S, Perlmann P, Webster HK, 1994. Lymphocyte responses to Plasmodium falciparum ring-infected erythrocyte surface antigen (Pf155/RESA) peptides in individuals with naturally acquired Plasmodium falciparum malaria. Am J Trop Med Hyg 50: 465-471.
25. Ockenhouse CF, Schulman S, Shear HL, 1984. Induction of crisis forms in the human malaria parasite Plasmodium falciparum by γ-interferon-activated, monocyte-derived macrophages. J Immunol 133: 1601-1608.
26. Mshana RN, Boulandi J, Mshana NM, Mayombo J, Mendome G, 1991. Cytokines in the pathogenesis of malaria: levels of IL-Iβ, IL-4, IL-6, TNF-α and IFN-γ in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol 34: 131-139.
27. Chougnet C, Deloron P, Lepers JP, Rason MD, Savel J, Coulanges P, 1990. Longitudinal study of the cellular response to Pf 155/RESA and CS protein in Madagascar. Immunol Lett 25: 231-236.
28. Riley EM, Allen SJ, Troye-Blomberg M, Bennett S, Perlmann H, Andersson G, Smedman L, Perlmann P, Greenwood BM, 1991. Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. Trans R Soc Trop Med Hyg 85: 436-443.
29. Creasey A, Fenton B, Walker A, Thaithong S, Oliveira S, Mutambu S, Walliker D, 1990. Genetic diversity of Plasmodium falciparum shows geographical variation. Am J Trop Med Hyg 42: 403-413.
30. Ntoumi F, Mercereau-Puijalon O, Luty A, Georges A, Millet P, 1996. High prevalence of the third form of merozoite surface protein-1 in Plasmodium falciparum in asymptomatic children in Gabon. Trans R Soc Trop Med Hyg 90: 701-702.
31. Allan RJ, Rowe A, Kwiatkowski D, 1993. Plasmodium falciparum varies in its ability to induce tumor necrosis factor. Infect Immun 61: 4772-4776.
32. Astagneau P, Chougnet C, Lepers JP, Andriamangatiana-Rason MD, Deloron P, 1994, Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf155/RESA) protect against Plasmodium falciparum malaria. Int J Epidemiol 23: 169-175.